SARS-CoV-2系統B.1.1.7の出現の空間時間的侵入ダイナミクス
Moritz U G Kraemer1,2, Verity Hill3,4, Christopher Ruis2,5
1Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil. a.rambaut@ed.ac.uk moritz.kraemer@zoo.ox.ac.uk s.scarpino@northeastern.edu oliver.pybus@zoo.ox.ac.uk.
まとめ
B.1.1.7のような重症急性呼吸器症候群コロナウイルス2 (SARS-CoV-2) 変種を理解するには,人間の行動と免疫を分析する必要があります. この研究は,移動と介入の影響を受けた空間的侵略のダイナミクスを明らかにしています.
科学分野:
- 流行病学
- ゲノミクス
- 公衆衛生
背景:
- 懸念されるSARS-CoV-2変種の出現は,パンデミック制御に課題を投げかけています.
- 変種の拡散を理解するには人間の行動と免疫を考慮する必要があります.
研究 の 目的:
- SARS-CoV-2 B.1.1.7 系統の空間的侵入ダイナミクスを調査する.
- 移動性,介入,および以前の免疫を含む,変種拡散に影響を与える要因を分析する.
主な方法:
- イギリスの人間の移動データ,ウイルスゲノム,コミュニティPCRデータの共同分析.
- 空間的侵入プロセスと変異成長率のモデル化
- 非薬学的介入と空間的な免疫の変化の影響を評価する.
主要な成果:
- B.1.1.7の多段階の空間侵入を特定した.
- B.1.1.7 早期の成長率は,移動性と非対称な系統の輸出に関連しています.
- 薬剤以外の介入による変異の広がり,以前の発症率の空間的変化.
結論:
- 変種の出現と拡散は,固有の伝染性,人間の行動,流行病学的文脈の複雑な相互作用によって影響を受けます.
- 変種の成長率を正確に解釈するには,行動的および疫学的要因を考慮する必要があります.
- これらのダイナミクスを理解することは 効果的なパンデミック制御戦略に不可欠です
さらに関連する動画
関連する概念動画
Infection
9.4K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
9.4K
Steps in Outbreak Investigation
263
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
263
Viral Recombination
24.1K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.1K
Single Nucleotide Polymorphisms-SNPs
17.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.0K
Viral Mutations
35.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
35.9K
Causality in Epidemiology
1.1K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.1K


